share_log

复星医药(600196.SH):控股子公司获药品注册申请受理

Fosun Pharmaceutical (600196.SH): Holding subsidiary accepted drug registration application

Gelonghui Finance ·  Apr 8 04:27

Gelonghui, April 8, 丨 Fosun Pharmaceutical (600196.SH) announced that the registration application for drugs independently developed by the holding subsidiary Shanghai Fosun Pharmaceutical Industry Development Co., Ltd. was recently accepted by the State Drug Administration.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment